NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the pricing of its previously announced underwritten public offering of 6,849,316 shares of its common stock at a public offering price of $73.00 per share. All of the shares in the offering will be sold by Intra-Cellular Ther
Dow Jones futures edged higher overnight, along with S&P 500 futures and Nasdaq futures. Nvidia chipmaker Taiwan Semiconductor reports early Thursday, with huge implications for the chip sector. The stock market rally opened slightly higher but once again quickly headed lower, with the Nasdaq leading the retreat.
ORLANDO, Fla. — SpaceX launched Wednesday evening the first of a pair of Space Coast rockets in two days, both carrying batches of the company’s Starlink satellites. A Falcon 9 rocket carrying 23 of the internet satellites for SpaceX’s growing constellation lifted off at 5:26 p.m. Eastern time from Kennedy Space Center’s Launch Pad 39-A amid clear blue skies. This is the 12th flight of the ...
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|